SciHub
文献互助
期刊查询
一搜即达
科研导航
即时热点
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!
静静爱科研
Lv1
18 积分
2022-11-07 加入
最近求助
最近应助
互助留言
Classic biphasic pulmonary blastoma: A case report and review of the literature
7小时前
待确认
Hand-foot syndrome and survival in patients with advanced non-small-cell lung cancer receiving anlotinib: a subgroup analysis of data from the ALTER 0303 study
8小时前
已完结
Anlotinib in treatment of an elderly patient with recurrent advanced SCLC
8小时前
已完结
A novel multi-target tyrosine kinase inhibitor anlotinib combined with irinotecan has in-vitro anti-tumor activity against human small-cell lung cancer
8小时前
已完结
A Phase Ib/II Study of Pepinemab in Combination with Avelumab in Advanced Non–Small Cell Lung Cancer
1个月前
已完结
Anlotinib in patients with relapsed or refractory thymic epithelial tumors: a study of 50 cases
1个月前
已完结
Safety and feasibility of anlotinib in children with high risk, recurrent or refractory sarcomas: an open-label, single-centre, single-arm, phase Ia/Ib trial
1个月前
已关闭
Phase II Trial of Paclitaxel, Carboplatin, and Etoposide in Advanced Poorly Differentiated Neuroendocrine Carcinoma: A Minnie Pearl Cancer Research Network Study
2个月前
已完结
Selection of Chemotherapy in Advanced Poorly Differentiated Extra-Pulmonary Neuroendocrine Carcinoma
2个月前
已完结
Carboplatin and Etoposide for the Treatment of Metastatic Prostate Cancer with or without Neuroendocrine Features: A French Single-Center Experience
2个月前
已完结
没有进行任何应助
感谢
8小时前
感谢
1个月前
感谢
3个月前
感谢
5个月前
是否未上传完整
10个月前
感谢
2年前
感谢
2年前
确定
2年前
感谢
2年前
感谢
2年前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论